#1 Clinical Trials Search in Europe

Find a Clinical Trial

Search Trials by Disease

Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
Rare Diseases Treatments

Search Trials by Disease

Myotonic dystrophy Chronic hepatitis B Transferrin decreased Antiphospholipid antibodies Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Cognitive disorder Behcet's syndrome Polycystic liver disease Small cell lung cancer Corneal neovascularisation Mantle cell lymphoma refractory Iron overload Uterine leiomyosarcoma Ewing's sarcoma Myasthenia gravis More trials…
Learn about Rare Diseases

Langerhans’ cell histiocytosis – Treatment Hereditary motor and sensory neuropathy – Diagnostics Mast cell activation syndrome – Trials in Disease Glomerulonephritis membranous – Trials in Disease Pleural mesothelioma malignant – Diagnostics Lymphangioma – Treatment CADASIL – Treatment Pulmonary sarcoidosis – Trials in Disease Hepatic angiosarcoma – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics More diseases
Vaccine Clinical Trials
Pediatric Clinical Trials
Resources for Patients

Browse Innovative Treatments

IMA401 Gtaexs617 Lymecycline Amb-05X Azithromycin Dihydrate Irbesartan Peginterferon Beta-1A Magnesium Citrate Sepiapterin Relacorilant A/H1N1 INFLUENZA VACCINE Neratinib Wt1/Il15/Il15Ra Mrna Dc Cefaclor Iron HRS 9531 LIPASE Odm-111 Crovalimab Stiripentol More therapies…

Learn about Your Condition

Joint stabilisation Thromboembolectomy Bladder cancer stage III Relapsing multiple sclerosis Abdominal pain Decreased appetite Appendicitis Post procedural hypotension Congenital myopathy Breast cancer stage III Perthes disease Thrombocytosis Hereditary optic atrophy Diabetic nephropathy Oesophageal atresia More diseases
Healthy Volunteers
Patient Guide
Our Partners
About Us
Contact us
Region

🇪🇺 Europe
🇦🇹 Austria
🇭🇷 Croatia
🇨🇿 Czech Republic
🇩🇰 Denmark
🇪🇪 Estonia
🇫🇮 Finland
🇫🇷 France
🇩🇪 Germany
🇮🇸 Iceland
🇮🇹 Italy
🇱🇻 Latvia
🇱🇹 Lithuania
🇳🇱 Netherlands
🇳🇴 Norway
🇵🇱 Poland
🇵🇹 Portugal
🇷🇴 Romania
🇸🇰 Slovakia
🇸🇮 Slovenia
🇪🇸 Spain
🇸🇪 Sweden

Transitional cell carcinoma urethra

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Recruiting

1 1 1 1
Investigated Drugs:
+1
Study on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer

Not recruiting

2 1 1 1
Investigated Diseases:
Investigated Drugs:
- Enfortumab Vedotin
- Pembrolizumab
Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Drugs:
+4
Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Not recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
+2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

Transitional cell carcinoma urethra

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Study on Enfortumab Vedotin and Pembrolizumab for Patients with Advanced Urothelial Cancer

Study of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer

Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with Advanced Unresectable Urothelial Cancer

Investigational Drugs in This Location

Medical Conditions Being Studied in This Location

We use cookies